{
    "root": "2fa5b032-dcc5-09e1-e063-6294a90ad780",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "METHYLPHENIDATE HYDROCHLORIDE",
    "value": "20250305",
    "ingredients": [
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLPHENIDATE HYDROCHLORIDE",
            "code": "4B3SC438HI"
        }
    ],
    "indications": "Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of:\n                  \n                     Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults\n                     Narcolepsy",
    "contraindications": "Methylphenidate hydrochloride extended-release tablets (2.2) : May switch to Methylphenidate hydrochloride extended-release tablets when the 8-hour dosage of Methylphenidate hydrochloride extended-release tablets corresponds to the titrated 8-hour dosage of methylphenidate hydrochloride tablets. Must be swallowed whole and never crushed or chewed",
    "warningsAndPrecautions": "Methylphenidate hydrochloride extended-release tablets, USP are available as follows:\n                  10 mg: White to off white, round shaped, uncoated, tablets debossed with “FM4” on one side and “plain” on other side.\n                  Bottles of 100 tablets              NDC 70010-042-01\n                  Bottles of 30 tablets                NDC 70010-042-03\n                  20 mg: White to off white, round shaped, uncoated, tablets debossed with “FM5” on one side and “plain” on other side.\n                  Bottles of 100 tablets                   NDC 70010-043-01\n                  Bottles of 30 tablets                     NDC 70010-043-03\n                  \n                     NOTE:Methylphenidate hydrochloride extended-release tablets, USP are color-additive free.\n\n \n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].\n                  Protect from moisture.\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.\n                  \n                     Disposal\n                  \n                  Comply with local laws and regulations on drug disposal of CNS stimulants. Dispose of remaining, unused, or expired Methylphenidate hydrochloride extended-release tablets, USP by a medicine takeback program or by an authorized collector registered with the Drug Enforcement Administration. If no take-back program or authorized collector is available, mix Methylphenidate hydrochloride extended-release tablets, USP with an undesirable, nontoxic substance to make it less appealing to children and pets. Place the mixture in a container such as a sealed plastic bag and discard Methylphenidate hydrochloride extended-release tablets, USP in the household trash.",
    "adverseReactions": "Hypersensitivity to methylphenidate or other components of Methylphenidate hydrochloride extended-release tablets. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate\n  \n   [\n   \n    see Adverse Reactions (6)]\n  \n   .\n \n  \n                     Concomitant treatment with monoamine oxidase inhibitors (MAOIs), or within 14 days following discontinuation of treatment with an MAOI, because of the risk of hypertensive crises\n  \n   [\n   \n    see Drug Interactions (7.1)]\n  \n   ."
}